Loomis, Sayles & Company’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-13
Closed -$5K 985
2023
Q4
$5K Buy
+13
New +$4.6K ﹤0.01% 895
2023
Q1
Sell
-50
Closed -$12K 1036
2022
Q4
$12K Buy
50
+8
+19% +$1.9K ﹤0.01% 788
2022
Q3
$10K Buy
42
+37
+740% +$11.3K ﹤0.01% 673
2022
Q2
$2K Sell
5
-9
-64% -$2.93K ﹤0.01% 900
2022
Q1
$6K Buy
+14
New +$5.48K ﹤0.01% 777
2021
Q4
Sell
-35
Closed -$15K 917
2021
Q3
$15K Buy
+35
New +$14.8K ﹤0.01% 749
2021
Q2
Sell
-50
Closed -$14K 927
2021
Q1
$14K Buy
50
+10
+25% +$2.86K ﹤0.01% 711
2020
Q4
$11K Sell
40
-75,000
-100% -$21M ﹤0.01% 722
2020
Q3
$20.6M Sell
75,040
-64,777
-46% -$17.1M 0.03% 228
2020
Q2
$31.8M Buy
139,817
+10,834
+8% +$2.13M 0.05% 150
2020
Q1
$19.6M Sell
128,983
-1,423
-1% -$219K 0.04% 167
2019
Q4
$19.6M Sell
130,406
-10,033
-7% -$1.46M 0.03% 221
2019
Q3
$19.9M Buy
140,439
+12,714
+10% +$1.75M 0.04% 212
2019
Q2
$16M Buy
127,725
+9,656
+8% +$1.14M 0.03% 246
2019
Q1
$13M Buy
118,069
+21,539
+22% +$2.24M 0.03% 299
2018
Q4
$9.46M Buy
96,530
+34,390
+55% +$3.73M 0.02% 330
2018
Q3
$7.67M Buy
62,140
+794
+1% +$89K 0.02% 426
2018
Q2
$6.09M Sell
61,346
-2,165
-3% -$199K 0.01% 509
2018
Q1
$5.61M Sell
63,511
-1,134
-2% -$106K 0.01% 521
2017
Q4
$6.38M Buy
64,645
+5,253
+9% +$515K 0.01% 493
2017
Q3
$5.72M Sell
59,392
-1,540
-3% -$139K 0.01% 506
2017
Q2
$5.76M Buy
60,932
+6,714
+12% +$618K 0.01% 501
2017
Q1
$4.42M Sell
54,218
-12,878
-19% -$1.08M 0.01% 525
2016
Q4
$5.69M Sell
67,096
-1,064
-2% -$83.7K 0.01% 512
2016
Q3
$5.08M Sell
68,160
-17,226
-20% -$1.37M 0.01% 517
2016
Q2
$6.48M Buy
85,386
+48,916
+134% +$3.56M 0.02% 480
2016
Q1
$2.53M Sell
36,470
-5,321
-13% -$320K 0.01% 522
2015
Q4
$2.52M Buy
41,791
+23,972
+135% +$1.44M 0.01% 531
2015
Q3
$964K Buy
17,819
+5,043
+39% +$294K ﹤0.01% 556
2015
Q2
$742K Buy
+12,776
New +$713K ﹤0.01% 590

Other funds holding WST